ClosedGrantWon by DAXOR CORPORATIONSBIR Phase II SBIR
Far Forward and En Route Decision Assist in the Treatment of Hemorrhage
Department of Defense - Air Force
Closed
NAICS 541512
Source: sbir_sttr
OverviewIntelligenceProposals
Key Details
- Posted Date
- Response Deadline
- NAICS Code
- 541512
- Source
- sbir_sttr
- Award Amount
- $749,967
- Awarded To
- DAXOR CORPORATION
Description
Daxor proposes to develop the Fluorescent BVA-200F, a non-nuclear, ruggedized, portable, and forward-deployable version of the commercially available BVA-100. The proposed BVA-200F will be a uniquely accurate, combat-deployable decision assist capability
Key Dates
Posted:→Deadline:
Frequently Asked Questions
Is this grant still open?+
No — the response deadline for this grant has passed (April 15, 2022). Browse other active Department of Defense opportunities on Bureauify.
How do I apply for this grant?+
Review the full solicitation documents on the source website (SAM.gov or Grants.gov), prepare your proposal per the instructions, and submit before the deadline. Use Bureauify to track the opportunity and get reminders.
Who won this grant?+
This grant was awarded to DAXOR CORPORATION for $749,967. Use Bureauify to analyze this vendor's contract history and win patterns.
Intelligence
- Win probability analysis
- Competitive landscape
- Incumbent analysis
- Price-to-win estimate
- Similar awards history
Data sourced from sbir_sttr